FTC Requires Divestitures in Generic Pharmaceutical Markets Even Though the Target Had Exited the Markets Alert
Hedge Fund’s Settlement With FTC Highlights Limits To HSR Investment-Only Exemption Alert
Federal Trade Commission Reaches Record $1.2 Billion Proposed “Pay for Delay” Settlement with Cephalon and Injunctive Relief Restricting Future Similar Settlements of Patent Infringement Cases Alert
Weil Serves as Antitrust Counsel to Actavis in the Sale of its Branded Respiratory Portfolio to AstraZeneca Article